Repligen (RGEN) Share-based Compensation (2010 - 2026)
Repligen's (RGEN) quarterly Share-based Compensation came in at $83.2 million in Q1 2026, up 1181.18% year-on-year from $6.5 million in Q1 2025, and up 487.95% on a QoQ basis from -$21.4 million in Q4 2025.
Repligen (RGEN) Share-based Compensation (2010 - 2026) Analysis & Trends
Repligen (RGEN) has 17 years of Share-based Compensation data on file, last reported at $83.2 million in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 1181.18% year-over-year to $83.2 million in Q1 2026; TTM through Mar 2026 was $83.2 million, a 229.86% increase from a year earlier, with the FY2025 full-year figure at $63.7 million, up 12.74% from the prior year.
- Share-based Compensation for Q1 2026 stood at $83.2 million, up from -$21.4 million in the prior quarter.
- Over the last five years, Share-based Compensation for RGEN reached as high as $83.2 million in Q1 2026 and fell as low as -$21.4 million in Q4 2025.
- Historically, Share-based Compensation has averaged $21.5 million across 5 years, with a median of $8.8 million in 2024.
- Across the five-year window, Share-based Compensation surged 2743.6% in 2023 and plunged 207.51% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at $1.2 million in 2022, then surged by 1011.27% to $13.2 million in 2023, then plunged by 207.51% to -$14.2 million in 2024, then plunged by 50.98% to -$21.4 million in 2025, then surged by 487.95% to $83.2 million in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $83.2 million in Q1 2026, -$21.4 million in Q4 2025, and $72.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 45.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 13.10 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 58.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 26.79 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 10.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 51.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 40.92 Mn |
| 10 | Repligen | 7.75 Bn | 6.77 Bn | 108.28 Mn | 83.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83.20 Mn |
| Mar 31, 2026 | 83.20 Mn |
| Dec 31, 2025 | -21.45 Mn |
| Dec 31, 2025 | -21.45 Mn |
| Sep 30, 2025 | 72.00 Mn |
| Sep 30, 2025 | 72.00 Mn |
| Jun 30, 2025 | 8.38 Mn |
| Jun 30, 2025 | 8.38 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | -14.21 Mn |
| Dec 31, 2024 | -14.21 Mn |
| Sep 30, 2024 | 23.06 Mn |
| Sep 30, 2024 | 23.06 Mn |
| Jun 30, 2024 | 9.88 Mn |
| Jun 30, 2024 | 9.88 Mn |
| Mar 31, 2024 | 8.78 Mn |
| Mar 31, 2024 | 8.78 Mn |
| Dec 31, 2023 | 13.21 Mn |
| Dec 31, 2023 | 13.21 Mn |